In clinical practice, a common response to uncontrolled asthma is to step up treatment, with an attendant
increase in healthcare costs and risk of side-effects; yet, as highlighted in the previous section, there are many
modifiable contributors to both uncontrolled symptoms and exacerbations. There was a general perception
that asthma guidelines over-emphasised pharmacological treatment, and promoted a “one-size-fits-all”
approach to asthma management. The latter concern also applied to the prominence previously given to